hoodb.com

노바티스, SMA 유전자치료제 ‘졸겐스마’ FDA 승인

|

You are leaving and open the following URL" of about "smn" news

news.google.com/rss/articles/CBMiVkFVX3lxTFBGYmZhcWt1M0ZBUEZ4MlBuUzFBZlNTMHNyOERJYkJSbjFFZ2hUdlRFV0d3X2V0aHpHUnVLWV9YdlF6QU9zbmNOT2dURnBWcGt2RVNMSVBR?oc=5


Continue Opne >

smn: 노바티스, SMA 유전자치료제 ‘졸겐스마’ FDA 승인


More smn news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/IL/smn.xml in /var/www/hoodb/function.php on line 339
1736439839-
Warning: file_put_contents(aCache/aaa/gnews/IL//smn.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About smn

from
1736439840-1736286124

Warning: filemtime(): stat failed for aCache/search/il/smn in /var/www/hoodb/function.php on line 339
1736439840-

smn, 노바티스, SMA 유전자치료제 ‘졸겐스마’ FDA 승인 2022 smn

노바티스, SMA 유전자치료제 ‘졸겐스마’ FDA 승인

Choose Your Country or Region


Back to Top



노바티스, SMA 유전자치료제 ‘졸겐스마’ FDA 승인

Copyright © 2020-2021 hoodb.com. All Rights Reserved.